上海沿浦(605128.SH):獲得新項目定點通知書
格隆匯1月2日丨上海沿浦(605128.SH)公佈,全資子公司惠州沿浦汽車零部件有限公司於近期收到重要客户(惠州某公司)的《定點通知書》,上海沿浦將為該客户一款車型的整椅生產供應汽車座椅骨架總成產品。因該項目開發任務重開發週期短,所以該項目由母公司上海沿浦公司牽頭做技術設計報價方案,並聯合全資子公司惠州沿浦汽車零部件有限公司和柳州沿浦汽車科技有限公司一起做項目前期開發並確保該項目按照客户規定的時間節點順利量產。目前根據客户預測,本次公吿的定點通知書的新項目的生命週期是5年(2025年-2030年),預計產生大約7.2億元人民幣的營業收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.